Sotera Health FY2024 revenue up 4.9% to $1.10B; net income down to $44M; provides 2025 outlook

Sotera Health Co

2024-FY EPS reported $0.16 revenue$1,100,441,000

Q4 net revenues down 6.5% to $290M; net income $12M ($0.04 EPS) vs $39M ($0.14 EPS) in Q4 2023.
Full-year net revenues $1.10B (+4.9%); net income $44M ($0.16 EPS) vs $51M ($0.18 EPS) in 2023.
Adjusted EBITDA $549M (+3.9% YoY); Adjusted EPS $0.70 (down $0.02 YoY).
2025 guidance: net revenue growth 4.0%-6.0%, Adjusted EBITDA growth 4.5%-6.5% constant currency.
CEO highlights 19th consecutive year of revenue growth, >80% customer satisfaction, Sterigenics expansion, Nelson Labs growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.